Matthew Labriola

13PUBLICATIONS
88CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Social and community informaticsInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Sep 05, 2026
Association between smoking, tumor genetics, and outcomes in men with metastatic prostate cancer.

|Aug 05, 2026
Clinical and genomic determinants of extraordinary response and resistance to androgen receptor pathway inhibitors in men with metastatic androgen pathway modulator sensitive (APMS) prostate cancer.

|Jul 10, 2026
Clinical and genomic predictors of sipuleucel-T outcomes in men with metastatic androgen pathway modulator resistant prostate cancer.

|May 28, 2026
EMETPRO: a multicentric, international, retrospective analysis evaluating patients with metastatic hormone-sensitive prostate cancer with early progression.

|Aug 23, 2024
DNA-Damaging Therapies in Patients With Prostate Cancer and Pathogenic Alterations in Homologous Recombination Repair Genes.

Laura S Graham, Nicholas C Henderson, Olesia Kellezi

|Jul 17, 2024
Clinical implications of Wnt pathway genetic alterations in men with advanced prostate cancer.

Amanda Broderick, Elizabeth Pan, Jinju Li

Pageof 3

Frequent Collaborators

8 joint publications

Andrew J Armstrong

6 joint publications

Laura S Graham

6 joint publications

Tanya Dorff

6 joint publications

Rana R McKay